The in vitro studies of primary AML blasts demonstrate that zosuquidar enhanced the cytotoxicity of daunorubicin, idarubicin, mitoxantrone, or Mylotarg in the majority of AML cases which expressed active P-gp. Here, PGP is linked to acute myeloid leukemia.